Chapter 8
Supply and Biosecurity
Vital Farms' physical supply chain splits its risk in two opposite directions. On the disease side it is deliberately dispersed — more than 600 small pasture farms, so a single avian-influenza hit is a fraction of a percent of laying capacity, and no Vital farm was lost to the virus in 2025 [1] while the U.S. industry culled roughly 79 million hens across 2024 and 2025 [2]. On the processing and cost side it is concentrated — nearly all eggs pass through one Springfield facility, and gross margin is tethered to corn and soy.
Two geometries of risk
Outdoor access is the entire premise of the brand — Certified Humane rules require at least 108 square feet of pasture per hen and daily time outside — and it is also the feature that, in principle, raises exposure to a virus carried by wild birds. That tension is the natural first question for anyone weighing an egg producer whose hens are, by design, not sealed indoors. The evidence in the filings resolves it in an unexpected direction: the pasture model is more resilient to a flock-level disease event than the concentrated cage industry, because the same standard that puts hens outside also forces production across hundreds of small, physically separated sites.
The reader-relevant distinction is between two kinds of risk that this chapter treats separately. Flock risk — losing birds to disease — is spread thin. Facility and input risk — losing the one plant that washes and packs the eggs, or absorbing a swing in feed cost — is not. A margin-of-safety buyer who screens out businesses that could fail should weigh the second far more heavily than the first.
Distribution as biosecurity
Vital contracts with a network that has grown from about 275 farms in 2021 to more than 425 in 2024 and over 600 in 2025 [3]. Management's own framing of why that matters dates back to the first HPAI wave: because the birds sit on many small sites rather than a few large ones, a single infected farm is "less than half a percent of our productive capacity," and the model has "resilience simply in … not having a small number of very concentrated farm sites, which once affected, affects all of the hens on that site" [4].
The record since then supports the claim more than it undercuts it. Vital experienced HPAI at exactly one farm in fiscal 2024 and at none in fiscal 2025 — through the worst two years of avian influenza the U.S. egg industry has seen [5]. The contrast with the concentrated model is stark. Cal-Maine, the largest U.S. shell-egg producer, lost approximately 3.1 million laying hens and 577,000 pullets from HPAI at just two of its facilities in fiscal 2024, with operations at both sites halted until they could be cleared and repopulated [6]. A single-site loss at a concentrated producer exceeds the entire bird count on any one Vital farm by orders of magnitude.
Sources: Vital Farms FY2025 10-K, MD&A [7] and Q4 FY2021 call [8]; Cal-Maine FY2024 10-K [9].
The industry backdrop shows what Vital avoided. Cal-Maine's filings record roughly 40.2 million commercial layer hens and pullets depopulated nationally in calendar 2024 and a further 39.0 million through May 2025, pulling the U.S. table-egg flock down to about 285.5 million hens from a five-year average near 313 million [10]. That supply destruction is what drove commodity egg prices to record highs and back down — the same price swing that widened Vital's shelf-price gap in 2026 (Cash Conversion). The disease that most threatens the industry has, so far, done its damage to Vital indirectly through the commodity price, not directly through its own flock.
The counter-fact belongs in the same breath. Distribution lowers the odds of a total loss; it does not make the network immune, and a new disease has appeared alongside HPAI. Egg drop syndrome (EDS) hit nine Vital farms in fiscal 2024 and twelve in fiscal 2025; the company has begun procuring vaccinations but states plainly it "may not be able to obtain enough vaccinations to treat all of the flocks in our network" [11]. A widespread outbreak that moved through the Pasture Belt, or a demand shock from the mere perception of disease, would still hurt — distribution protects the asset base, not the market. Cal-Maine, for its part, has spent more than $75 million on biosecurity since 2015, a reminder that the concentrated model defends itself with capital where the pasture model defends itself with geography [12].
One facility, one region
Where the flock is dispersed, the processing is not. Almost every Vital egg is washed and packed at a single plant — Egg Central Station in Springfield, Missouri, roughly 153,000 square feet after its 2022 expansion [13] and capable of packing more than 7.5 million eggs a day [14]. The company names the exposure directly: "A substantial amount of our shell egg processing occurs at our Egg Central Station … Any damage or disruption at this facility … may harm our business" [15]. A separate risk factor sizes the geographic dimension: operations are "geographically consolidated," and "a major tornado or other natural disaster or extreme weather event within the regions in which we operate could seriously disrupt our entire business" [16]. Springfield sits in a part of the country where tornadoes are a routine hazard, and the entire farm network is clustered in the same weather-defined Pasture Belt.
This is the concentration a bankruptcy-averse buyer should weigh most. A prolonged loss of the one plant would strand the eggs the company is contractually bound to buy from its farmers regardless of whether it can sell them [17], turning a distributed supply advantage into a single-point liability at the neck of the funnel. It is the mirror image of the disease picture: many farms, one throat.
The mitigation is underway and is the item that most changes this risk. Vital broke ground in 2025 on Vital Crossroads, a second washing-and-packing facility with onsite cold storage in Seymour, Indiana, expected to be fully operational in 2027 [18]. Read alongside The Growth Engine, the second plant is not only capacity for the $2 billion ambition — it is the end of single-facility dependence, moving Vital from one processing site to two in a different state and a different weather system. The qualifier is timing: the plant's construction was slowed in the 2026 pull-back, so the de-risking arrives on a 2027 schedule that management has already shown it will flex to protect cash. Until it opens, the single-facility exposure stands.
The feed tether
The cost side is where Vital most resembles a commodity business. The price it pays contracted farmers for eggs is reset quarterly for changes in feed cost, so movements in corn and soybean meal flow through to Vital's gross margin by contract design; the farmer funds the birds and feed as working capital, but the input-price risk lands on Vital [19]. The filing quantifies the sensitivity: a hypothetical 10% move in the weighted-average cost of these ingredients — primarily corn and soy — would have changed fiscal-2025 cost of goods sold by approximately $12.9 million, with packaging adding a further $5.2 million per 10% move [20].
Source: FY2025 10-K, Item 7A market-risk disclosures [21]; percentage of gross profit derived from FY2025 gross profit of $285.7M.
Sized against the business, the input tether is real but not, on its own, the dominant swing factor. Against FY2025 gross profit of $285.7 million, a 10% feed move is about 4.5% of gross profit, and feed plus packaging together about 6.3%. Vital runs commodity derivative contracts on conventional feed to blunt part of this [22]. The more damaging commodity exposure sits on the other side of the model: not the cost of feed going in, but the price of commodity eggs on the shelf next to Vital's, which is what compressed velocities and margin in 2026 (Recovery or Reset). Vital is a commodity business at both ends, but the ends are not the same size — the demand-side price gap has moved earnings far more than the feed line has.
What it means for a margin-of-safety buyer
The net read is that the physical supply chain is a genuine, under-credited strength on disease and a real but shrinking liability on concentration. The distributed farm network has done in practice what management said it would — carried Vital through the worst avian-influenza years with a single lost farm while competitors depopulated millions of birds — and that is a structural feature, not luck, rooted in the same outdoor standard that defines the brand. The offsetting exposures are the single Springfield plant in tornado country and the feed tether, both of which are bounded: the plant risk is being halved by a second facility on a 2027 timeline, and the feed risk is sized at roughly 4.5% of gross profit per 10% move and partly hedged.
The evidence points to a supply chain that lowers, rather than raises, the odds of the kind of catastrophic operational failure a bankruptcy-averse investor screens for — the flock cannot be wiped out at one site, the balance sheet carries no processing-plant debt, and the second facility removes the last obvious single point of failure. The main risk to that read is a low-probability, high-severity event the distribution does not cover: a Pasture-Belt-wide disease sweep, a new pathogen like EDS outrunning the vaccine supply, or a natural disaster striking Springfield before Vital Crossroads opens. What would change the read is a widening EDS footprint across the network in 2026–2027, or a slip in the Vital Crossroads schedule that leaves single-facility dependence in place longer than the 2027 target implies.